Bionano Genomics, Inc. Common Stock (BNGO)
Bionano Genomics, Inc. is a biotechnology company specializing in genome analysis, primarily through its optical genome mapping technology. The company's platform enables researchers and clinicians to detect structural variations in DNA with high resolution, facilitating insights into genetic diseases, cancer, and complex genetic disorders. Bionano's technologies are used in research, medical diagnostics, and agrigenomics to improve understanding of genomic structure and variation.
Company News
Bionano Genomics completed a public offering of 5 million shares and warrants, raising approximately $10 million gross proceeds to be used for working capital and general corporate purposes.
Bionano Genomics has priced a public offering of 5 million shares and accompanying warrants at $2.00 per share, expecting to raise approximately $10 million for working capital and general corporate purposes.
BNGO earnings call for the period ending March 31, 2024.
Here is how AbCellera Biologics Inc. (ABCL) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.
Penny stocks under $1 to watch this week. The post Best Penny Stocks To Buy Now? 6 Under $1 To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.